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958DLP. In any event, just because radiation dose is
difﬁcult to estimate does not mean that it should not
be openly discussed with patients, especially because
it is a public concern. We are currently working on a
more accurate approach for estimation of effective
dose from DLP for coronary CTA for virtually all
contemporary scanners.
One of the goals of our paper was to stimulate
awareness of the need for DRLs in all cardiovascular
procedures involving ionizing radiation, of which
coronary CTA is an important example. This is an
area in which the cardiology community has fallen
behind other ﬁelds (e.g., pediatric radiology). DRLs
for individual examinations are often framed in
terms of the 75th percentile of the distribution of
patient doses in a particular population. However,
with such high between-center variability, as pointed
out by Drs. Castellano and Nicol, careful thought is
needed for the most constructive approach to devel-
oping such reference levels. If a population-based
75th percentile threshold were used uniformly, most
patients would be ﬂagged as exceeding the DRL
in some laboratories; consequently, the concept
of DRL could be rendered of little use for patient
radiation protection.
Another important implication of the great vari-
ability in radiation doses is that, in real-world prac-
tice, doses may not be nearly as low as those reported
by experts using the latest equipment in selected
patient populations. Thus, to paraphrase Mark Twain,
rumors of the demise of the “radiation problem” in
cardiac imaging have been greatly exaggerated. The
UK laboratories’ median coronary CTA DLP range of
200 to 1000 mGycm suggests that, using a cardiac-
speciﬁc conversion factor, the median coronary CTA
effective dose at these sites ranged fromw5 to 30 mSv.
The existence of such dose levels in contemporary
practice underscores both the need for continued
efforts to reduce doses to patients and the need for
patient-centered imaging, shared decision making,
and better communication with our patients.*Andrew J. Einstein, MD, PhD
Sandra S. Halliburton, PhD
Thomas C. Gerber, MD, PhD
Leslee J. Shaw, PhD
*Cardiology Division
Columbia University Medical Center
622 West 168th Street, PH 10-203A
New York, New York 10032
E-mail: andrew.einstein@columbia.edu
http://dx.doi.org/10.1016/j.jacc.2014.06.1156Please note: This work was supported by National Heart, Lung, and Blood
Institute grants R13 HL112549 and R01 HL109711.R EF E RENCE S
1. Einstein AJ, Berman DS, Min JK, et al. Patient-centered imaging: shared
decision making for cardiac imaging procedures with exposure to ionizing
radiation. J Am Coll Cardiol 2014;63:1480–9.
2. Einstein AJ, Elliston CD, Arai AE, et al. Radiation dose from single-heartbeat
coronary CT angiography performed using a 320-detector row volume
scanner. Radiology 2010;254:698–706.REPLY: The Murky World of Effective Dose
for Cardiovascular CTThe letter by Drs. Castellano and Nicol in response to
my editorial introduces an additional complexity
regarding radiation exposure from cardiovascular
computed tomography (CT), namely the difﬁculty in
measuring the actual dose that any given patient re-
ceives. Because of this difﬁculty and lack of agree-
ment on what to measure and how to express the
result, a measurement is not even attempted on a
regular basis in clinical practice. Most imaging sites
use a generic estimate of radiation exposure that is
included in the report of ﬁndings.
In either case, that is, trying to obtain an accurate
measurement in each patient with all the unknowns
and difﬁculties mentioned by Castellano and Nicol
or using a generic estimate of radiation exposure,
the ordering physician and the imaging center need
the guidelines provided in the report by Einstein
et al. so that a meaningful discussion of the issues
of radiation exposure can be initiated with the
patient.
I agree with the conclusion of Drs. Castellano
and Nicol that, until the scientiﬁc community can
agree on how to obtain these measurements and
how best to express them to patients, discussions
with our patients will lack some degree of unifor-
mity. It would be a stretch to say that these discus-
sions are evidence based. For the vast majority of
patients, this is irrelevant; however, the real issue is
understanding the “risk,” not the details of actual
exposure to radiation.*Lewis Wexler, MD
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